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Pentachlorophenol (CAS Registry no. 87-86-5;
also referred to as penta, pentachlorofenol,
2,3,4,5,6-pentachlorophenol, and chlorophen)
is a chlorinated aromatic compound that has
been used extensively as a fungicide. Impurities
comprise approximately 10% of technical or
commercial grade pentachlorophenol and con-
sist of several congeners of the chlorophenols,
primarily the higher chlorinated congeners of
dibenzo-p-dioxins and dibenzofurans [National
Toxicology Program (NTP) 1989; Schwetz
et al. 1974]. Pentachlorophenol was ﬁrst regis-
tered as a wood preservative in the United States
in 1936 (Ahlborg and Thunberg 1980) and has
also been used in ropes, paints, adhesives, can-
vas, insulation, and brick walls [Agency for
Toxic Substances and Disease Registry
(ATSDR) 2001; Proudfoot 2003]. Use by the
general public was restricted in 1984, and
pentachlorophenol application was limited to
industrial areas (e.g., utility poles, railroad
crossties, fence posts). The 95th percentile of
urinary pentachlorophenol concentration was
approximately 1.0–2.0 µg/L in the 1999–2002
National Health and Nutrition Examination
Survey III [Centers for Disease Control and
Prevention (CDC) 2005]. The comparable ﬁg-
ure from a population-based study in Germany
in 1998 was 3 µg/L (Schulz 2007); in that
study, levels had decreased since 1990. 
Case reports (Bishop and Jones 1981;
Greene et al. 1978) and case–control studies of
hematopoietic cancers published in the 1980s
and 1990s (Hardell et al. 1981, 1994, 1995;
Kogevinas et al. 1995; Pearce et al. 1986b;
Smith and Christophers 1992; Smith et al.
1984; Woods et al. 1987) raised concerns
about the risk of non-Hodgkin lymphoma and
soft-tissue sarcoma in relation to pentachloro-
phenol exposure. Other studies examined the
carcinogenic effect of pentachlorophenol in
experimental animals. Some of the most exten-
sive animal studies were conducted by the
NTP in B6C3F1 mice (NTP 1989) and F344
rats (NTP 1999). The type of cancer seen
among the exposed animals included hepato-
cellular adenomas and carcinomas in male and
female mice (a relatively common cancer
among these animals, particularly in the
males); rarer types of cancer including adrenal
medullary pheochromocytomas in male and
female mice, hemangiosarcomas in female
mice, and malignant mesothelioma and nasal
squamous cell carcinoma in male rats. 
Evaluation of available literature con-
ducted in the 1990s by the International
Agency for Research on Cancer (IARC) and
the U.S. Environmental Protection Agency
(EPA) classiﬁed pentachlorophenol as a “possi-
ble human carcinogen” based on sufficient
information in animal assays but limited data
in humans (IARC 1999; U.S. EPA 1991). The
U.S. EPA assessment, completed in 1991, was
conducted before the publication of most of
the case–control and cohort studies focusing
on pentachlorophenol exposure. IARC, in
1999, noted that the most consistent ﬁndings
among the studies available at that time were
for soft-tissue sarcoma and non-Hodgkin
lymphoma. One concern noted about the data
was the potential effect of recall bias in the
case–control studies, although this was
thought to be an unlikely explanation for all of
the observed associations. Another concern
noted in the IARC summary (IARC 1999)
was the perceived inability to distinguish a pos-
sible confounding effect of the contaminants,
particularly polychlorinated dibenzo-p-dioxins
(PCDDs), within chlorophenols. 
We reviewed the currently available epi-
demiologic studies of cancer risk in relation to
pentachlorophenol exposure to explore the
availability of relevant data pertaining to distin-
guishing the effect of pentachlorophenol from
that of other chlorophenols and from dioxins.
Additionally, we reviewed studies to determine
the extent to which more recent studies address
the limitations of the previous data. 
Methods
We searched the MEDLINE database
(National Library of Medicine, Bethesda,
MD) for studies related to pentachlorophenols
and cancer risk, using “pentachlorophenol”
and “chlorophenol” as search terms. We also
reviewed references within relevant reports. 
We included studies in this review if infor-
mation was presented pertaining speciﬁcally to
pentachlorophenol exposure. In the absence
of either a quantitative or qualitative penta-
chlorophenol measure, we also accepted
studies that included an assessment of chloro-
phenol exposure and additional information
on specific jobs that would have likely used
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OBJECTIVE: Pentachlorophenol, a fungicide widely used as a wood preservative, was classiﬁed in
1999 by the International Agency for Research on Cancer as a possible human carcinogen. We
reviewed currently available data to determine the extent to which recent studies assist in distin-
guishing the effect of pentachlorophenol from that of its contaminants (e.g., dioxins and other
chlorophenols). 
DATA SOURCES AND EXTRACTION: We performed a systematic review of published studies pertain-
ing to cancer risk in relation to pentachlorophenol exposure, focusing on results pertaining speciﬁ-
cally to all cancer sites and speciﬁc hematopoietic cancers, and data pertaining to risks associated
with other types of chlorophenols, dioxins, or furans. 
SYNTHESIS: The pentachlorophenol studies presented considerable evidence pertaining to
hematopoietic cancers, with strong associations seen in multiple studies, in different locations, and
using different designs. There is little evidence of an association between these cancers and
chlorophenols that contain fewer than four chlorines. The extension of a large cohort study of
sawmill workers, with follow-up to 1995, provided information about risks of relatively rare cancers
(e.g., non-Hodgkin lymphoma, multiple myeloma), using a validated exposure assessment proce-
dure that distinguishes between exposures to pentachlorophenol and tetrachlorophenol. In contrast
with dioxin, pentachlorophenol exposure has not been associated with total cancer incidence or
mortality.
CONCLUSIONS: The updated cohort study focusing on pentachlorophenol provides increased statis-
tical power and precision, and demonstrates associations between hematopoietic cancer and penta-
chlorophenol exposure not observed in earlier evaluations of this cohort. Contaminant confounding
is an unlikely explanation for the risks seen with pentachlorophenol exposure. 
KEY WORDS: cancer, childhood leukemia, chlorophenols, dioxins, furans, multiple myeloma, non-
Hodgkin lymphoma, pentachlorophenol, soft-tissue sarcoma. Environ Health Perspect 116:1001–1008
(2008). doi:10.1289/ehp.11081 available via http://dx.doi.org/ [Online 11 April 2008]pentachlorophenol rather than other chloro-
phenols. We excluded two cohort studies from
workplaces with exposures to other carcinogens
linked to hematopoietic cancers because data
were not presented that allowed estimation of
effects speciﬁcally for pentachlorophenol. These
excluded studies evaluated formaldehyde-
exposed workers in a plywood mill (Robinson
et al. 1987) and a Swedish tannery cohort with
a variety of exposures, including formaldehyde
and azo and benzidine dyes (Mikoczy and
Hagmar 2005). Pentachlorophenol represented
< 10% of the chlorophenol exposure in a
cohort study of sawmill workers in Finland
(Jäppinen et al. 1989) and in a study of cancer
incidence in the area surrounding a mill (Lampi
et al. 1992), and these studies were also
excluded. We excluded studies that presented
data only for a combined exposure such as
chlorophenols, or chlorophenols and phenoxy
herbicides (Garabedian et al. 1999; Hooiveld
et al. 1998; Hoppin et al. 1998; Kogevinas
et al. 1997; Ott et al. 1987; van Balen et al.
2006; Wingren et al. 1990). The other studies
we identified but did not include were two
small surveys (< 200 participants) of exposed
workers that contained very limited informa-
tion pertaining to cancer mortality (Cheng
et al. 1993; Gilbert et al. 1990), as well as stud-
ies of nasopharyngeal cancer (Mirabelli et al.
2000; Zhu et al. 2002). 
Results
Case–control studies of hematopoietic cancers.
The case–control studies of pentachloro-
phenol and speciﬁc hematopoietic cancer were
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Table 1. Case–control studies of non-Hodgkin lymphoma, soft-tissue sarcoma, and multiple myeloma risk and in relation to pentachlorophenol exposure.
Reference, location, Cases and controls [no. (source)],
Disease demographic data source of exposure data Results
Non-Hodgkin lymphoma
Pearce et al. 1986b 83 cases (cancer registry) Chlorophenols: OR = 1.3 (95% CI, 0.6–2.7)
New Zealand 168 cancer controls and 228 population controls Fencing work: OR = 2.0 (95% CI, 1.3–3.01)
Men, age < 70 years Structured interview
Woods et al. 1987 576 cases (cancer registry) Chlorophenols: OR = 0.99 (95% CI, 0.8–1.2)
USA (Washington State) 694 population controls Increased risk (OR > 1.5) for wood preservers and
Males, age 20–79 years  Structured interview  chlorophenols manufacturers but not for lumber 
grader (OR = 0.94)
Hardell et al. 1994 105 cases (hospital records); High (> 1 week continuously or 1 month
Sweden 355 population controls total) exposure to pentachlorophenols: OR = 8.8
Males, age 25–85 years Self-administered questionnaire with follow-up  (95% CI, 3.4–24)
telephone interview if needed
Kogevinas et al. 1995 32 cases (death certiﬁcates for all countries; Pentachlorophenols: OR = 2.75 (95% CI, 0.45–17.0)
Europe cancer registries for seven countries) High pentachlorophenols: OR = 4.19 (95% CI, 0.59–29.6)
Primarily male (31 of 32) 158 controls (nested case–control study within
a cohort study of exposed workers)a
Company records and industrial hygienist review; 
cumulative exposure scores for various 
chlorophenols and dioxins
Non-Hodgkin lymphoma and Hodgkin lymphoma
Smith and Christophers 1992 52 cases (cancer registry), Chlorophenols: OR = 1.4 (95% CI, 0.3–6.1)
Australia  52 cancer controls and 52 population controls 4 cases and 4 controls (1 population and 3
Males, age ≥ 30 years Deceased cases and controls excluded cancer controls) had deﬁnite pentachlorophenol
Structured interview exposure.
Soft-tissue sarcoma
Smith et al. 1984 82 cases (cancer registry), Chlorophenols: OR = 1.5 (95% CI, 0.5–4.5)
New Zealand 92 cancer controls Variable results (ORs from 0.7 to 1.9) for fencing and 
Males, age 20–80 years Structured interview sawmill/timber merchant jobs
Woods et al. 1987 128 cases (cancer registry), Chlorophenols: OR = 0.99 (95% CI, 0.7–1.5)
USA (Washington State) 694 population controls Lumber grader: OR = 2.7 (95% CI, 1.1–6.4) 
Males, age 20–79 years Structured interview Variable results (ORs from 0.79 to 4.8) for other high-, 
medium-, and low-exposure jobs 
Smith and Christophers 1992 30 cases (cancer registry), Chlorophenols ≥ 1 day: no cases with this exposure; 
Australia 30 cancer controls and 52 population controls no cases and 2 controls (1 population and 1 cancer
Males, age ≥ 30 years Deceased cases and controls excluded control) had deﬁnite pentachlorophenol exposure
Structured interview
Hardell et al. 1995  434 cases (hospital records; cancer registry),  High (more than 1 week continuously or 1 month total) 
Meta-analysis of four studiesb 948 population controls exposure to pentachlorophenols: OR = 2.8 (95% CI,
Sweden Self-administered questionnaire with follow-up 1.5–5.4)
Males, ages 25–80 years telephone interview if needed
Kogevinas et al. 1995 12 cases (death certiﬁcates for all countries; Pentachlorophenols: no exposed cases or controls
Europe cancer registries for 7 countries), 44 controls
Males (nested case–control study within cohort study 
of exposed workersa)
Company records and industrial hygienist review, 
cumulative exposure scores for various 
chlorophenols and dioxins
Multiple myeloma
Pearce et al. 1986a 76 cases and 315 cancer controls No association (OR = 1.1) with chlorophenol exposure, 
New Zealand work in a sawmill or timber merchant, or treating fence
Males, age < 70 years posts 
Stronger associations with fencing work (OR = 1.6; 95% 
CI, 0.9–2.7) and jobs at a sawmill or timber merchant 
that involved potential exposure to chlorophenols 
(OR = 1.4; 95% CI, 0.5–3.9)
aTwenty-four cohorts from 11 countries; total n = 21,183 workers, exposures to phenoxy herbicides or chlorophenols. bHardell and Sandstrom (1979), Eriksson et al. (1981),
Hardell and Eriksson (1988), and Eriksson et al. (1990).conducted between 1970 and 1995 (Tables 1
and 2). Two case–control studies of non-
Hodgkin lymphoma (Pearce et al. 1986b;
Woods et al. 1987), one study that combined
Hodgkin and non-Hodgkin lymphoma
(Smith and Christophers 1992), two studies of
soft-tissue sarcoma (Smith et al. 1984; Woods
et al. 1987), and one of multiple myeloma
(Pearce et al. 1986a) assessed occupational
exposure to chlorophenols with limited data
specifically relating to potential exposure to
jobs or activities with likely exposure to penta-
chlorophenol. These studies reported no or
weak associations [odds ratios (ORs) < 1.5]
with chlorophenols, but showed somewhat
stronger risks with some speciﬁc jobs involving
wood preservation or fencing work (jobs gener-
ally associated with pentachlorophenol). 
More detailed assessment of pentachloro-
phenol exposure was presented within the
population-based case–control studies of non-
Hodgkin lymphoma (Hardell et al. 1994)
(Table 1) and soft-tissue sarcoma (Hardell
et al. 1995) conducted in Sweden. The 1995
meta-analysis of soft-tissue sarcoma (Hardell
et al. 1995) was based on four previously pub-
lished studies (Erikkson et al. 1981, 1990;
Hardell and Eriksson 1988; Hardell and
Sandrstrom 1979) that had presented data
pertaining to chlorophenols (Table 2). The
reanalysis used the original study data to gen-
erate estimates specifically for pentachloro-
phenol. In these studies from Sweden, cases
were identiﬁed through hospital records or a
cancer registry, and controls were identified
through a population registry (for matching
to living cases) and the national death registry
(for matching to deceased cases). With the
exception of one of these studies (Hardell
and Eriksson 1988), the matching process
resulted in an equal proportion of deceased
cases and controls. A self-administered ques-
tionnaire with follow-up telephone interview,
if needed, was used to obtain detailed infor-
mation pertaining to work history, including
information on specific jobs and exposures.
Next-of-kin proxy respondents were used for
deceased cases and controls. This information
was used to create an exposure measure for
specific chemicals, including chlorophenols
and pentachlorophenols. Exposures in the
5 years immediately preceding diagnosis (or a
corresponding reference year for controls)
were excluded to account for a minimum
latency period. High exposure was deﬁned as
1 week or more continuously or at least
1 month total. A strong association [OR =
8.8; 95% confidence interval (CI), 3.4–24]
was observed between high exposure to pen-
tachlorophenol and risk of non-Hodgkin
lymphoma (Hardell et al. 1994) and in the
meta-analysis of four soft-tissue sarcoma stud-
ies (OR = 2.8; 95% CI, 1.5–5.4 for high pen-
tachlorophenol exposure) (Hardell et al.
1995). 
A nested case–control study within a
large, international cohort of workers exposed
to phenoxy herbicides or chlorophenols
(Kogevinas et al. 1995) also provided a more
detailed assessment of pentachlorophenol
and related exposures. Job records and com-
pany records pertaining to chemicals used
during specific processes were used by three
industrial hygienists to evaluate exposure to
21 specific chemicals [phenoxy herbicides,
chlorophenols, PCDDs and polychlorinated
dibenzofurans (PCDFs), process chemicals,
and raw materials]. The estimated associa-
tions with non-Hodgkin lymphoma in that
study are relatively imprecise, given the small
size (n = 32 cases and 158 controls), but there
is evidence of an association with any penta-
chlorophenol exposure (OR = 2.75; 95% CI,
0.45–17.0) and specifically with the high
cumulative exposure category (OR = 4.19;
95% CI, 0.59–29.6). In contrast with the
elevated point estimates seen with penta-
chlorophenol, there was no evidence of an
association with the chlorophenols containing
fewer than four chlorines (ORs = 0.65, 0.80,
and 1.03 for 2,4,5-trichlorophenol, 2,4,6-
trichlorophenol, and 2,4-dichlorophenol,
respectively). No estimate was provided for
2,3,4,6-tetrachlorophenol because of lack of
model convergence (1 exposed case and
7 exposed controls). The associations seen
with dioxins appeared somewhat weaker
than those seen with pentachlorophenol
[ORs = 1.84 for any dioxin or furan, 1.93
for 2,3,7,8-tetrachlorodibenzo-p-dioxin
(TCDD), and 2.75 for pentachlorophenol],
although the small sample size makes precise
comparisons difficult. There were only
12 cases of soft-tissue sarcoma identified
within the cohort, and none of these cases or
the 44 matched controls had been exposed to
pentachlorophenol. 
Cohort studies in pentachlorophenol-
exposed workers. Cohort studies of workers
exposed to pentachlorophenol in sawmills and
in a manufacturing plant have been conducted
(Table 3). Ramlow et al. (1996) examined the
mortality risk in a cohort of 770 male workers
at Dow Chemical Company, Michigan
Division. This plant manufactured pen-
tachlorophenol from the late 1930s to 1980.
Exposure to dioxins, primarily hexa-, hepta-,
and octa-CDDs and CDFs also occurred
within this cohort (Collins et al. 2007; Ott
et al. 1993). Potential for exposure to penta-
chlorophenol was assessed by evaluating avail-
able industrial hygiene data, including some
quantitative environmental and personal
breathing zone measurements of pentachloro-
phenol in conjunction with detailed employ-
ment records. Each job was assigned an
estimated exposure intensity score and the
estimated cumulative exposure index was cal-
culated for each subject based on the product
of job duration and intensity, summed across
all jobs. Collins et al. (2007) and Ott et al.
(1993) used a similar process to estimate
cumulative exposure to TCDD and the
hexa-CDD to octa-CDD ratio. Mortality risk
for all causes of cancer was not elevated, and
Pentachlorophenol and cancer risk
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Table 2. Case–control studies of chlorophenol and soft-tissue sarcoma risk included in Hardell et al. meta-analysis (1995). 
Swedish region,
case accrual,  Cases [no. (percent deceased)]
Reference sex and age  and controls (no.)a Resultsb
Hardell and Sandstrom 1979  Umeå (northern Sweden) 52 cases (60% deceased) Any chlorophenols
1970–1977, hospital records 208 controls OR = 6.6 (p < 0.001)
Males, ages 26–80 years
Eriksson et al. 1981  Five counties (southern Sweden)  110 cases (35% deceased) Any chlorophenols
1974–1978, cancer registry 220 controls OR = 3.3 (95% CI, 1.3–8.1)
Sex and age not speciﬁed
Hardell and Eriksson 1988 Three counties (northern Sweden) 54 (67% deceased), Any chlorophenols, no association
1978–1983, cancer registry 311 controls (33% deceased)
Males, ages 25–80 years
Eriksson et al. 1990 Upsala (central Sweden) 218 (64% deceased) Low chlorophenols
1978–1986, cancer registry 212 controls OR = 0.89 (95% CI, 0.40–2.0)
Males, ages 25–80 years High chlorophenols
OR = 5.24 (95% CI, 1.69–16.3)
aThe matching design used in all of the studies except Hardell and Eriksson (1988) resulted in an equal proportion of deceased cases and controls within each study. bThe publications
presented data pertaining to chlorophenols, but reanalysis with the meta-analysis (Hardell et al. 1995) used original study data to generate estimates speciﬁcally for pentachlorophenol. there were no deaths due to soft-tissue sar-
coma or Hodgkin disease. Increased standard-
ized mortality ratios (SMRs) were seen for
some forms of lymphopoietic cancers
(Table 3), particularly in the high-exposure
group (defined as cumulative exposure ≥ 1).
Similar results were seen with a 15-year
latency period. There was some indication of
an increased risk of lymphopoietic cancer with
the dioxin measures, but these effects were
somewhat weaker than those seen with penta-
chlorophenol. (For all lymphopoietic cancers,
trend p-value = 0.34 for TCDD, 0.53 for the
hexa-CDD to octa-CDD ratio, and 0.08 for
pentachlorophenol.) 
Another larger cohort study involved
> 26,000 male sawmill workers from 14 mills
in British Columbia, Canada (Hertzman et al.
1997). This study was recently updated by
Demers et al. (2006) in an analysis that
included specific measures of pentachloro-
phenol and tetrachlorophenol exposures and
with an extension of the follow-up period
from 1989 to 1995 (Table 3). Demers et al.
(2006) included 26,487 men who had worked
at least 1 year (or 260 days total) between
1950 and 1995, with 2,658 workers from the
mills that did not use the fungicides included
in the unexposed group in the exposure–
response analyses. The authors used record
linkage through the provincial and national
death files and cancer incidence registries to
assess mortality (from first employment
through 1995) and cancer incidence (from
1969, when the provincial cancer registry
began, through 1995). Plant records were
available to determine work histories for study
cohort members, including duration of work
within different job titles. Representative
exposures were determined for three or four
time periods for each mill. Demers et al.
(2006) developed a retrospective exposure
assessment based on interviews with senior
workers (≥ 5 years of experience) at each mill
(9–20 workers for each time period; mean,
15 years of experience). For current exposures,
the process was compared with urinary meas-
urements, resulting in correlation coefﬁcients
of 0.76 and 0.72 in two different sampling
periods (Hertzman et al. 1988). The validity
of this method was also demonstrated in com-
parison with a method based on industrial
hygienist assessment (Teschke et al. 1989,
1996). A cumulative dermal chlorophenol
exposure score was calculated for each worker
by summing, across all jobs, the product of the
job-title–speciﬁc exposure score and the length
of employment in that job. Records from each
mill were used to determine the specific
chlorophenol content of the fungicides used at
specific time periods. In general, tetra-
chlorophenol was used increasingly in place of
pentachlorophenol after 1965. This informa-
tion was used to develop pentachlorophenol-
and tetrachlorophenol-specific exposure
scores. The correlation between the estimated
pentachlorophenol and tetrachlorophenol
exposures was 0.45 (Demers et al. 2006). 
Hertzman et al. (1997) reported only a
weak association between the total chloro-
phenol measure and non-Hodgkin lymphoma
risk. Based on 65 cases, the standardized inci-
dence ratios (SIRs) across ﬁve levels of cumula-
tive exposure to chlorophenates were 0.68,
0.59, 1.04, 10.2, and 1.30. No association was
seen with risk of multiple myeloma (SIRs 1.18,
0.93, 0.66, 0.19, and 1.11, across the exposure
levels, based on 19 cases). However, in the
more recent analysis of pentachlorophenol
exposure, Demers et al. (2006) observed expo-
sure effects for non-Hodgkin lymphoma and
multiple myeloma. Table 4 presents the results
from Demers et al.’s incidence data. The
authors also presented a similar set of results
Cooper and Jones
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Table 3. Summary of cohort studies of cancer risk in pentachlorophenol exposed workers. 
Total no.,
Cohort, duration of work, follow-up, Exposure assessment,
location Reference inclusion criteria outcome assessment Resultsa
Dow manufacturing plant, USA (Michigan)
Ramlow et al. 1996 n = 770 men Work history (job records) and All cancers: SMR = 0.95
Mean duration: not reported industrial hygiene assessment; Elevated risk of lymphatic cancer 
Mean follow-up: 26.1 years developed exposure intensity mortality, particularly at higher 
Worked some time between  and cumulative exposure scores intensity exposures
1937 and 1980 in a relevant  for pentachlorophenol and for dioxinsb Any pentachlorophenol exposure 
department Death certiﬁcate (underlying cause) All lymphopoietic cancers (seven cases):
SMR = 1.4 (95% CI, 0.56–2.88) 
Other and unspeciﬁed lymphopoietic 
cancers (ﬁve cases):cSMR = 2.0 (95% 
CI, 0.65–4.7)
High exposure (cumulative exposure ≥ 1)
All lymphopoietic cancers: 
SMR = 1.91 (95% CI, 0.86–4.24)
Trend p-value = 0.08 
Other and unspeciﬁed lymphopoietic 
cancers: SMR = 2.58 (95% CI, 0.98–6.8)
Trend p-value = 0.19 
Sawmill workers, Canada (British Columbia)
Hertzman et al. 1997 n = 23,829 men (1,498 incident  Work history (job records) and Weak or no risk of non-Hodgkin
cancer cases; 105 cancer deaths) industrial hygiene assessment; lymphoma and multiple myeloma
Mean duration: 9.8 years  developed cumulative exposure
Mean follow-up: 24.5 years scores for total chlorophenols
Worked at least 1 year (or 260  Death certiﬁcate (underlying cause)
days total) between 1950 and  and cancer registry (incidence)
1985; follow-up through 1989
Demers et al. 2006 Same as Hertzman et al. 1997  Same as Hertzman et al. 1997 except All cancers: SMR = 1.00, SIR = 0.99
except follow-up through 1995 that cumulative exposure scores  Elevated risk of non-Hodgkin lymphoma 
2,571 incident cancer cases were developed for pentachlorophenol and multiple myeloma incidence and
1,495 cancer deaths and tetrachlorophenol mortality; evidence of exposure–effect
response; weaker or no risk seen with 
tetrachlorophenol (Table 4)
SIR, standardized incidence ratio. 
aElevated indicates an SMR of ≥ 1.5. bTCDD and the hexa-CDD to octa-CDD ratio. cTwo of these cases were multiple myeloma and three cases would now be classified as
non-Hodgkin lymphoma. from the analysis of the mortality data. Liver
cancer was also associated with penta-
chlorophenol exposure. Analyses using a 10-
year (data not shown) or 20-year (Table 4)
latency period showed similar or stronger asso-
ciations with respect to pentachlorophenol
exposure and risk of non-Hodgkin lymphoma
(trend p-value = 0.02) and multiple myeloma
(trend p-value = 0.03), but not liver cancer
(trend p-value = 0.38). Similar results were also
seen in the analyses using a 10-year latency
period presented by Demers et al. (2006). The
risk of non-Hodgkin lymphoma or multiple
myeloma in relation to tetrachlorophenol
(Table 4) was somewhat smaller than for
pentachlorophenol, particularly in the analysis
including a 20-year latency period. The num-
ber of incident cases of soft-tissue sarcoma was
small (n = 23), and lower risks of this cancer
were seen in the higher exposure groups for
pentachlorophenol and for tetrachlorophenol. 
Studies of childhood cancers. A recent
cohort study in Canada (Heacock et al. 2000)
and a case–control study in Taiwan (Ali et al.
2004) examined childhood cancer risk in rela-
tion to parental occupational exposure to
pentachlorophenol. The cohort study
(Heacock et al. 2000) was based in the off-
spring of the male workers in the British
Columbia sawmill workers cohort studied by
Demers et al. (2006). In this analysis of child-
hood cancers, however, the exposure metric
was based on total chlorophenol exposure,
rather than on separate estimates for penta-
chlorophenol and tetrachlorophenol.
Marriage and birth records were linked to
identify 19,675 children born to these fathers
between 1952 and 1988. Forty incident
childhood cancers (including 11 leukemias,
9 brain cancers, and 4 lymphomas) were
identiﬁed among these children (with follow-
up through 19 years of age) through the link-
ing of birth records to the provincial cancer
registry. The incidence rates were similar to
those expected based on sex-, age-, and calen-
dar year–standardized rates, with a standard-
ized incidence rate of 1.0 (95% CI, 0.7–1.4)
for all cancers, 1.0 (95% CI, 0.5–1.8) for
leukemia, and 1.3 (95% CI, 0.6–2.5) for
brain cancer. 
Ali et al. (2004) conducted a population-
based case–control study of leukemia (n = 103
cases) and brain cancer (n = 74 cases) in
patients diagnosed before 30 years of age in
Taiwan. Occupational history for jobs held
> 6 months since 16 years of age was obtained
using a structured interview with each of the
parents and any patient (or control) who was at
least 16 years of age. The analysis focused on
speciﬁc periods of exposure (e.g., preconception
deﬁned as any job ending > 1 year before the
child’s birth; perinatal, any job held between
1 year before the child’s birth and the child’s
birth). Adjusting for smoking history (for the
participant and the parents) and exposure to
medical radiation, Ali et al. (2004) observed
strong but statistically imprecise associations
between paternal work as a wood treater and
risk of leukemia: for any exposure period,
5 exposed cases and 2 exposed controls (OR =
16.0; 95% CI, 1.8–145.4); for the preconcep-
tion period, 4 exposed cases and 1 exposed con-
trol (OR = 12.2; 95% CI, 1.4–109.2); for the
perinatal period, 4 exposed cases and 1 exposed
control (OR = 13.0; 95% CI, 1.4–125.5). No
other information is available pertaining to the
specific material used by these workers
(Christiani D, personal communication). 
Discussion
The available epidemiologic studies present
evidence pertaining to cancer risk and occu-
pational exposure to pentachlorophenol, par-
ticularly with respect to hematopoietic
cancers. The literature base is quite broad,
with multiple studies, in different locations,
and using different designs. The more recent
studies have allowed more focused analysis,
specifically of risks associated with penta-
chlorophenol exposure. In addition, recent
studies have demonstrated a relatively strong
ability of pentachlorophenol (compared with
other organochlorine pesticides tested) with
respect to inhibition of the cytotoxic activity
of natural killer cells (Reed et al. 2004; Taylor
et al. 2005), an effect of particular relevance
given the role of natural killer cells in tumor
surveillance (Smyth et al. 2002). 
Synthesis of studies of pentachlorophenol
and hematopoietic cancers. The strongest of
the available studies, in terms of design, is the
large sawmill cohort study conducted in
British Columbia, Canada, and recently
updated by Demers et al. (2006). This study
used a population-based cancer registry,
which allowed for the analysis of cancer inci-
dence. The exposure assessment procedure
was developed specifically to address the
exposure situations and setting of the work-
site, and the reﬁned exposure metric provides
an ability to distinguish effects of pen-
tachlorophenol and tetrachlorophenol. Recall
bias is not an issue given the design of the
study, in which the exposure assessment is
derived independently of the cancer classiﬁca-
tion and is based on company records rather
than self-reported work histories. Common
behaviors, such as smoking and use of alcohol,
Pentachlorophenol and cancer risk
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Table 4. Cancer incidence risk in relation to estimated pentachlorophenol and tetrachlorophenol exposure in sawmill workers, British Columbia, Canada.a
Pentachlorophenol exposure Tetrachlorophenol exposure
No latency 20-year latency No latency 20-year latency
Cancer Exposure-years Obs RR 95% CI Obs RR 95% CI Obs RR 95% CI Obs RR 95% CI
Non-Hodgkin lymphoma < 1 38 1.0 (Referent) 46 1.0 (Referent) 50 1.0 (Referent) 78 1.0 (Referent)
1–2 13 1.3 0.70–2.5 13 1.8 0.59–3.5 11 0.90 0.47–1.8 8 1.7 0.78–3.5
2–5 24 1.9 1.1–3.3 21 2.1 1.1–3.7 20 1.3 0.80–2.3 5 1.3 0.49–3.3
≥ 5 17 1.7 0.91–3.2 12 2.0 0.97–4.1 11 1.5 0.79–3.0 1 1.5 0.20–11.1
(Trendb) (0.06) (0.02) (0.14) (0.32)
Multiple myeloma < 1 6 1.0 (Referent) 8 1.0 (Referent) 15 1.0 (Referent) 19 1.0 (Referent)
1–2 4 2.1 0.57–7.6 3 1.7 0.43–7.0 1 0.27 0.04–2.0 3 1.7 0.48–5.9
2–5 4 1.3 0.34–5.0 6 2.1 0.62–7.0 5 1.1 0.38–2.9 3 1.8 0.48–6.7
≥ 5 11 4.2 1.4–12.9 8 3.8 1.2–12.3 4 1.8 0.58–5.6 0
(Trend) (0.02) (0.03) (0.48) (0.30)
Soft-tissue sarcoma < 1 18 1.0 (Referent) 20 1.0 (Referent) 16 1.0 (Referent) 23 1.0 (Referent)
1–2 3 0.64 0.18–2.2 1 0.34 0.04–2.6 3 0.77 0.23–2.66 0
2–5 2 0.18 0.04–0.85 2 0.33 0.07–1.6 4 0.66 0.22–1.99 0
≥ 50 0 0 0
(Trend) (0.11) (0.12) (0.43) (1.0)
Liver < 1 3 1.0 (Referent) 19 1.0 (Referent) 11 1.0 (Referent) 19 1.0 (Referent)
1–2 4 4.1 0.89–18.8 1 0.61 0.08–4.7 7 2.7 1.0–6.9 1 0.61 0.08–4.7
2–5 12 8.5 2.2–32.4 1 0.44 0.44–3.5 3 0.52 0.14–1.88 1 0.44 0.05–3.5
≥ 5 2 1.4 0.21–9.2 0 0 0
(Trend) (0.18) (0.38) (0.58) (0.38)
Obs, number of observed cases. Analyses based on Poisson regression using the lowest exposure group as the referent group, adjusting for age and time period. 
aData from Demers et al. 2006. bTrend p-value.have not been associated with the types of
cancers associated with pentachlorophenol
exposure in this study (non-Hodgkin lym-
phoma, multiple myeloma), so it is difficult
to conceive of a way in which the observed
associations could be explained by confound-
ing by those factors. In addition, the use of an
internal comparison group for the analyses
reduces the likelihood of other potential con-
founders affecting the results. No information
is provided about the effect of adjustment for
tetrachlorophenol exposure on the penta-
chlorophenol results. However, because the
correlation between the two measures is rela-
tively low (r = 0.45), and for many of the can-
cers of interest the pentachlorophenol
associations are stronger than those seen with
tetrachlorophenol, it is unlikely that this
adjustment would attenuate the observed
associations with pentachlorophenol. 
However, even with a cohort study of this
size, there is limited statistical power to esti-
mate precise associations with relatively rare
cancers. Thus, the data from this cohort study
are complemented by the data from case–
control studies of speciﬁc lymphopoietic can-
cers. Strong associations were seen in a series
of case–control studies in Sweden between
high (defined as > 1 week continuously or
1 month total) exposure to pentachlorophenol
and non-Hodgkin lymphoma (Hardell et al.
1994) and soft-tissue sarcoma (Hardell et al.
1995), with ORs of 8.4 and 2.8, respectively.
In a small nested case–control study of non-
Hodgkin lymphoma (32 cases, 158 controls),
elevated point estimates (with wide CIs) were
seen with pentachlorophenol and high penta-
chlorophenol exposure measures, but there
was no evidence of an association (i.e., ORs
less than or approximately equal to 1.0) with
the di- and trichlorophenols (Kogevinas et al.
1995). Several limitations of individual stud-
ies can be noted, including the imprecision of
the estimates from the very smallest study and
the difﬁculty in obtaining accurate work his-
tories from proxy respondent in studies with a
rapidly fatal disease. Evaluating the collection
of studies, however, allows for a more consid-
ered analysis of the potential effect of these
limitations. For example, concern about the
effect of differential misclassiﬁcation of expo-
sure would be reduced if, as is the case in this
set of studies, the cohort and nested case–
control studies, in which exposure assessment
did not depend on interview data, generally
support the data from case–control studies
relying on self-reported job histories. 
One limitation to the observations from
the sawmill cohort study that should be noted
is the temporal difference in pentachlorophe-
nol and tetrachlorophenol exposures, with
tetrachlorophenol replacing pentachlorophenol
beginning around 1965. Thus, a longer follow-
up period may be needed to fully capture the
effect of tetrachlorophenol if a long latency
period (≥ 20 years) is assumed. 
The classifications used for the various
subtypes of lymphomas, leukemias, and sarco-
mas can be confusing and may not be applied
similarly in different studies, particularly when
conducted over different time periods or in
different locations by different investigators.
Any differences in disease definitions should
not produce a biased result within a study,
given that the disease classiﬁcation methods in
the available studies were independent of the
exposure classiﬁcation system. It is not clear if
potential inconsistencies in disease classifica-
tions contributed to the difference seen with
respect to soft-tissue sarcoma and penta-
chlorophenol exposure in Sweden compared
with the sawmill cohort in Canada, or if this
difference reflects a difference in population
susceptibility, other factors, or chance. 
Childhood leukemia and brain cancer
risks were not increased among children of
the sawmill workers in an analysis using the
chlorophenol, rather than the speciﬁc penta-
chlorophenol and tetrachlorophenol, meas-
ures (Heacock et al. 2000). In light of the
data from the case–control study by Ali et al.
(2004), however, additional studies with
focused exposure assessments for paternal or
maternal pentachlorophenol exposure may be
needed to determine if prenatal or early-life
exposures to pentachlorophenol influences
the risk of childhood cancers. 
Distinguishing effects of specific chloro-
phenols and contaminant. Contamination of
pentachlorophenol with dioxins and related
by-products occurs as part of the production
process, and the possible confounding effects
of these contaminants (particularly PCDDs)
is an important consideration in the evalua-
tion of the studies of manufacturing workers
(Kogevinas et al. 1995; Ramlow et al. 1996).
In a recent follow-up study, Collins et al.
(2007) reported an increased mean lipid-
adjusted serum level of TCDD in penta-
chlorophenol production workers from the
Dow Chemical Company Michigan plant
(8.0 pg/g lipid) compared with community
referents (3.3 pg/g lipid) or other worker ref-
erents (6.5 pg/g lipid) in the plant. These
measurements were taken > 20 years after
production work at the plant had ended. The
epidemiologic studies of TCDD have consis-
tently demonstrated associations with total
cancer mortality, with a combined SMR of
1.4 (95% CI, 1.1–1.7) seen in a recent analy-
sis of four cohorts (Steenland et al. 2004). In
contrast, the SMR for all cancer mortality in
the pentachlorophenol manufacturing work-
ers was 0.95 (Ramlow et al. 1996). The dis-
similarity between the observed patterns in
cancer risk for pentachlorophenol and
TCDD makes it unlikely that confounding
by this compound is a reasonable explanation
for the specific cancer risks seen with
pentachlorophenol exposure.
Other forms of dioxins (e.g., specific
hexa-, hepta-, and octa-CDDs) were substan-
tially elevated in the pentachlorophenol pro-
duction workers in the Collins et al. (2007)
follow-up study, with levels for some of the
congeners two to four times higher compared
with community referents, worker referents,
and trichlorophenol production workers in the
plant. For example, mean 1,2,3,6,7,8-hexa-
chlorodibenzo-p-dioxin levels were 150.6 pg/g
lipid in the pentachlorophenol production
workers compared with 68–78 pg/g lipid in
the other groups; comparable values for octa-
chlorodibenzo-p-dioxin were 2,594 pg/g lipid
in the pentachlorophenol and 439–616 pg/g
lipid in the other groups. Few studies have
examined risks associated with these forms of
dioxin, but there was no association between
plasma levels of 1,2,3,6,7,8-hexaCDD,
1,2,3,4,5,6,8-heptaCDD, or octaCDD levels
and lymphoma risk in a recent case–control
study of 100 non-Hodgkin lymphoma cases
and 100 controls (De Roos et al. 2005). 
TCDD has not been detected in techni-
cal-grade or commercial-grade pentachloro-
phenol (NTP 1989; Schwetz et al. 1974). In
studies of pentachlorophenol users (e.g., in
sawmill or other lumber operations), concern
about contaminant confounding should thus
focus on the major pentachlorophenol conta-
minants, hexachlorinated dibenzodioxins,
dibenzofurans, and chlorophenols (particularly
the primary contaminant, tetrachlorophenol).
As described previously, two studies included
measures of pentachlorophenol and tetra-
chlorophenol (Demers et al. 2006; Kogevinas
et al. 1995), and these studies suggested
stronger associations seen between multiple
myeloma and non-Hodgkin lymphoma and
pentachlorophenol than between these cancers
and tetrachlorophenol. 
Animal evidence also suggests that the cont-
aminants are an unlikely explanation for the
carcinogenicity associated with pentachloro-
phenol. Male rats exposed to a pure formula-
tion of pentachlorophenol (i.e., analytical grade
pentachlorophenol, which does not contain
chlorophenols, dioxin, or furan contaminants)
exhibited nasal squamous cell carcinomas and
mesotheliomas (NTP 1999). The technical-
grade pentachlorophenol formulation used in
the NTP bioassay (NTP 1989) comprises
approximately 90% pentachlorophenol, 4%
tetrachlorophenol, and 6% chlorohydroxy-
diphenyl ethers. The commercial-grade (EC-7)
formulation is composed of approximately
91% pentachlorophenol and 9% tetra-
chlorophenol. Both formulations of penta-
chlorophenol induced liver tumors in male and
female mice (NTP 1989). In the mouse studies,
the tumor response was similar, with only
slightly stronger responses with the technical
Cooper and Jones
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Tetrachlorophenol likely plays a minimal role
in the carcinogenicity of pentachlorophenol, as
the difference in potencies seen in the bioassays
is inversely related to the relative amounts of
tetrachlorophenol in each formulation (i.e., 4%
in technical-grade pentachlorophenol vs. 9% in
commercial-grade pentachlorophenol). 
Another group of contaminants reported
is hexaCDDs, which comprise 0.001% of
technical-grade pentachlorophenol and
0.00002% of commercial-grade pentachloro-
phenol (NTP 1989). The tumor responses
observed with the two formulations of penta-
chlorophenol were similar, although techni-
cal-grade pentachlorophenol showed a slightly
greater potency relative to commercial-grade
pentachlorophenol. It is unlikely that
hexaCDD is responsible for the carcinogenic-
ity observed in mice exposed to pentachloro-
phenol, considering there was a 50-fold
difference in the amount of this hexaCDD
congener in the technical-grade and EC-7
pentachlorophenol formulations. 
Conclusions 
Recent studies have improved our ability to
determine the specific role of pentachloro-
phenol compared with other chlorophenols
and contaminants in evaluating cancer risk.
These studies include the updated analysis of
the large cohort of sawmill workers (Demers
et al. 2006), serologic measurements of conta-
minant profiles in manufacturing workers
(Collins et al. 2007), and a more comprehen-
sive understanding of the risks associated or
not associated with specific forms of dioxins
(De Roos et al. 2005; Steenland et al. 2004).
The updated cohort study provides improved
precision for associations with cancer inci-
dence and mortality, with separate exposure
estimates for tetrachlorophenol and penta-
chlorophenol in a work setting without con-
current exposure to TCDD. Human and
animal data support the idea that the associa-
tions seen with specific cancers and penta-
chlorophenol cannot be explained by
contamination with tetrachlorophenol. These
new data provide a more focused framework
upon which the earlier case–control studies
can be evaluated and also provide support for
the idea that these earlier results cannot be
attributed to other substances or to recall bias.
Additional research pertaining to penta-
chlorophenol and cancer risk should focus on
the potential role in childhood cancers and
questions pertaining to factors affecting the
development of specific forms of hemato-
poietic cancers. The currently available data
do indicate, however, that specific hemato-
poietic cancer risks are observed with penta-
chlorophenol exposure and that these risks are
not likely to be due to dioxins or other
chlorophenol contaminants. 
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